RORγ inhibition would counteract the statin-induced SREBP2-dependent feedback regulation and reduce the tumor cholesterol biosynthesis rate without affecting the host cholesterol homeostasis (Cai et al., 2019). This evidence concerns the gene RORC and neoplasm.